Swiss pharmaceutical giant Roche said Monday it is accelerating the timeline for its Wegovy rival weight loss drugs following promising early stage trial data.
Related Posts
Trump signals U.S. and U.K. could reach ‘real trade deal’ without tariffs
U.S. President Donald Trump signaled the U.K. could broker a “real trade deal” and escape tariffs.
Chinese AI tool told researchers how to make bioweapons
Mindgard said it discovered in July that Kimi models K2.6 and K3 Swarm could evade developer’s safety limits.
B-STAR: A Self-Taught AI Reasoning Framework for LLMs
A direct correlation exists between an LLM’s training corpus quality and its capabilities. Consequently, researchers have invested a great deal…